¿Û¿Û´«Ã½

It's worth waiting for this company’s 62% discount to narrow

The aircraft leasing company's fleet is now fully utilised and the directors are targeting organic growth

This company has electrifying potential

A lithium company is progressing two major projects and is significantly undervalued

Does professional services group RBG have recovery potential?

The group’s profits have been hit this year, but they could bounce back in 2024

A medtech stock with potential to treble in value

The investment company’s portfolio is worth 151 per cent more than its market cap and there are hidden assets, too

A software provider with a potential 80% upside

It offers software and technical services to the defence, rail and aerospace companies and is delivering major uplifts in profit and margin

Cash return beckons for Arix shareholders

Shareholders in a company that holds a portfolio of early-stage biotechnology investments could be in line for a hefty cash return

This energy play has a healthcare arm thrown in for free

It is benefitting from a resurgent energy market but also offers a hidden jewel in medical imaging

Profits dip at Mission – but directors have plans to turn it around

Higher financing costs have taken their toll and investors must wait for solid earnings growth

This below-the-radar SME lender is undervalued

The company's shares are 24 per cent below tangible book value even though trading is strong

Journeo is en route to quadrupling its profit

It had delivered 41 per cent organic revenue growth, but the shares are modestly rated on a PE of 11